Innovative antibody approach targets deep-seated cancer mutations
For too long, cancer treatment has been a double-edged sword—the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.
Oct 30, 2023
0
39
For too long, cancer treatment has been a double-edged sword—the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.
Oct 30, 2023
0
39
Through study findings published in Cell Reports, a team of scientists at VCU Massey Cancer Center has discovered a previously unknown interaction between proteins that is responsible for supplying energy to tumor cells and ...
Sep 12, 2023
0
72
Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide, and only around 10% of patients survive for five years after being diagnosed.
Sep 11, 2023
0
39
Cancer cells-to-be accumulate a series of specific genetic changes in a predictable and sequential way years before they are identifiable as pre-malignancies, researchers at Stanford Medicine have found. Many of these changes ...
Jul 8, 2023
0
95
Cancer spreads throughout the human body in cunning, almost militaristic, ways. For example, it can manipulate our genetic make-up, take over specific cell-to-cell signaling processes, and mutate key enzymes to promote tumor ...
Jul 3, 2023
0
55
Immune checkpoint blockade therapies have been revolutionary in the treatment of some cancer types, emerging as one of the most promising treatments for diseases such as melanoma, colon cancer and non-small cell lung cancer.
May 15, 2023
0
74
An international research team has identified "born to be bad" colorectal tumors in people with early stage cancer, which could help medical experts pinpoint and better treat aggressive tumors.
Dec 19, 2022
0
76
Colorectal carcinoma is the second most common cause of cancer death in Germany. Although cancer research in recent years has been able to significantly improve early diagnosis and therapy, the resistance of advanced colorectal ...
Nov 17, 2022
0
52
While previous studies have linked commercial dietary supplements like nicotinamide riboside (NR), a form of vitamin B3, to benefits related to cardiovascular, metabolic and neurological health, new research from the University ...
Nov 11, 2022
1
1959
Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum. These tumors are removed by surgery, ...
Nov 9, 2022
0
1032